Court denies GSK appeal in Vectura intellectual property dispute - Sharecast.com
Inhalers listed in the Vectura accounts as generating revenue, or... | Download Scientific Diagram
Hikma Pharmaceuticals PLC and Vectura Group PLC to develop generic version of GlaxoSmithKline PLC's blockbuster Ellipta inhaler
Vectura joins the 'smart inhaler' party with Propeller partnership | Fierce Pharma
VECTURA SIGNS GLOBAL AGREEMENT WITH HIKMA TO DEVELOP GENERIC VERSIONS OF GSK'S ELLIPTA® PORTFOLIO
Inhalers listed in the Vectura accounts as generating revenue, or... | Download Scientific Diagram
Articles about Vectura Group plc
Vectura's Inhaler Sales May Suffer Over Philip Morris Backlash - Bloomberg
GlaxoSmithKline, needing a sales surge, wins FDA nod for $1B-plus prospect Trelegy | Fierce Pharma
UK pharma Vectura is latest to work with Propeller on connected inhalers | MobiHealthNews
Vectura Group, Hikma In Global Alliance | Contract Pharma
Hikma and Vectura collaborate to develop GSK generics
Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry. - Document - Gale Academic OneFile
Philip Morris takeover of Vectura denounced by COPD Foundation
How Much Does Breo Ellipta Cost? - PricePro Pharmacy
Hikma and Vectura to Produce Generic Versions of GSK's Ellipta Meds - Pharmaceutical Processing World
GSK ex-CFO swoops for Advair generics-maker Vectura in £958M Carlyle bid | S&P Global Market Intelligence
Drug Delivery to the Lungs 20
Vectura wins additional $10m patent damages against GSK
Vectura to merge with SkyePharma in £441m deal - PMLiVE
Track Record - Vectura
Vectura names Will Downie as new CEO
Propeller Health, Vectura ink collaborative connected-inhaler deal - MassDevice
